Extending the date

TGA issues guidance on post-expiry date usage of shortage-impacted treatment   The Therapeutic Goods Administration says tocilizumab vials continue to be stable for a further six months past their labelled expiry date. This follows the medicine being added to the list of products interchangeable at a pharmacy level.  Roche, the manufacturer of tocilizumab (Actemra) has confirmed